Group Chairmen Approve Policy On Industry Support; NCI Turns Down Request To “Launder” Contributions
In Brief: ACR to Move From Chicago To Washington D.C. Area; Hanks Astro President, Phillips President Elect
NTP Staff Members In Bethesda Told They Must Move
Four New Centers To Compete In ’84, DeVita Tells Pane
Diagnosis-Treatment Cidac contract Gets Recompetition Okay
Cancer Letter Closes Out 1983, 10th Year
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
